MetLife, Inc.METNYSE

Overview Intelligence Charts News Fundamentals DCF Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 94% recommend buying.

Consensus Rating

Buy

16 analysts·Moderate coverage

94%

Rating Distribution

Strong Buy

00%

Buy

1594%

Hold

16%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 20% higher.

Bear Case

$84.00

+6%

Consensus

$95.00

+20%

Bull Case

$101.00

+28%

Price Range16 analysts

Low

Consensus

High

$84.00

$101.00

Current Target

Current Price

$79.21

Upside to Target

$15.79

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$9.81(10 analysts)

P/E15x

Current: 15.3x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.51%

EPS+11.76%

FY2028

Rev+5.72%

EPS+12.37%

FY2029

Rev+5.27%

EPS+4.26%

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:-0.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 12, 2026Mizuho Securities

MetLife price target lowered to $100 from $102 at Mizuho

Target:$100.00

+26.8%from $78.89

Feb 10, 2026Evercore ISI

MetLife (MET) PT Lowered to $95 at Evercore ISI

Target:$95.00

+21.9%from $77.92

Feb 5, 2026UBS

MetLife price target raised to $98 from $94 at UBS

Target:$98.00

+25.6%from $78.01

Jan 14, 2026Mizuho Securities

MetLife price target raised to $102 from $101 at Mizuho

Target:$102.00

+32.3%from $77.08

Jan 13, 2026Wells Fargo

MetLife price target raised to $97 from $94 at Wells Fargo

Target:$97.00

+23.9%from $78.32

Jan 8, 2026UBS

MetLife price target lowered to $94 from $95 at UBS

Target:$94.00

+17.8%from $79.79

Jan 8, 2026Barclays

MetLife price target lowered to $90 from $98 at Barclays

Target:$90.00

+13.3%from $79.47

Jan 6, 2026Evercore ISI

MetLife downgraded to In Line from Outperform at Evercore ISI

Target:$97.00

+18.6%from $81.77

Dec 15, 2025Mizuho Securities

MetLife initiated with an Outperform at Mizuho

Target:$101.00

+22.2%from $82.62

Dec 15, 2025Morgan Stanley

MetLife price target raised to $101 from $97 at Morgan Stanley

Target:$101.00

+21.4%from $83.22

Oct 8, 2025Barclays

MetLife price target raised to $98 from $93 at Barclays

Target:$98.00

+18.4%from $82.75

Oct 7, 2025Morgan Stanley

MetLife price target raised to $97 from $94 at Morgan Stanley

Target:$97.00

+17.3%from $82.69

Sep 19, 2025Piper Sandler

MetLife downgraded to Neutral from Overweight at Piper Sandler

Target:$84.00

+6.2%from $79.07

Sep 15, 2025Wolfe Research

MetLife initiated with an Outperform at Wolfe Research

Target:$95.00

+18.1%from $80.46

Jul 14, 2025Morgan Stanley

MetLife price target lowered to $98 from $99 at Morgan Stanley

Target:$98.00

+26.1%from $77.75

Apr 2, 2025Piper Sandler

MetLife price target raised to $94 from $92 at Piper Sandler

Target:$94.00

+14.0%from $82.49

Feb 28, 2025Morgan Stanley

MetLife price target raised to $109 from $101 at Morgan Stanley

Target:$109.00

+26.5%from $86.18

Oct 2, 2024Piper Sandler

MetLife price target raised to $92 from $85 at Piper Sandler

Target:$92.00

+12.5%from $81.78

Sep 4, 2024Barclays

Barclays Starts MetLife (MET) at Overweight

Target:$91.00

+17.4%from $77.52

Aug 1, 2024Bank of America Securities

MetLife price target lowered to $96 from $99 at BofA

Target:$96.00

+24.9%from $76.85

Jul 10, 2024Morgan Stanley

MetLife price target raised to $83 from $82 at Morgan Stanley

Target:$83.00

+18.7%from $69.92

May 22, 2024Argus Research

MetLife (MET) PT Raised to $80 at Argus

Target:$80.00

+9.4%from $73.15

May 6, 2024Piper Sandler

MetLife (MET) PT Lowered to $82 at Piper Sandler

Target:$82.00

+15.6%from $70.94

Mar 13, 2024CFRA

MetLife (MET) PT Raised to $77 at CFRA

Target:$77.00

+6.0%from $72.67

Jan 8, 2024Goldman Sachs

Goldman Sachs Upgrades MetLife (MET) to Buy

Target:$80.00

+16.1%from $68.92

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance